Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03072043 |
|---|---|
| Brief Title: | Phase 1b/2 Safety and Efficacy of APR-246 w/Azacitidine for tx of TP53 Mutant Myeloid Neoplasms |
| First Submitted : | March 2, 2017 |
| First Submitted that Met QC Criteria : | March 2, 2017 |
| First Posted : | March 7, 2017 |
| Results First Submitted : | November 13, 2020 |
| Results First Posted with QC Comments : | December 11, 2020 |
| Results First Submitted that Met QC Criteria : | February 8, 2021 |
| Results First Posted : | February 25, 2021 |
| Last Update Submitted that Met QC Criteria : | January 14, 2022 |
| Last Update Posted : | January 24, 2022 |